欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/V/0242/001
药品名称Exitel Plus Tablets
活性成分
    • febantel embonate 150.0 mg
    • praziquantel 50.0 mg
    • pyrantel embonate 144.0 mg
剂型Tablet
上市许可持有人Chanelle Pharmaceuticals Manufacturing Ltd. Loughrea Co. Galway Ireland
参考成员国 - 产品名称Ireland (IE)
Exitel Plus Tablet for Dogs
互认成员国 - 产品名称
    • Italy (IT)
    • Germany (DE)
    • Denmark (DK)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
    • Portugal (PT)
    • Greece (GR)
    • Sweden (SE)
    • Slovakia (SK)
    • Slovenia (SI)
    • Romania (RO)
    • Hungary (HU)
    • Lithuania (LT)
    • Latvia (LV)
    • Czechia (CZ)
    • Cyprus (CY)
    • Estonia (EE)
      Exitel Plus
许可日期2009/10/27
最近更新日期2023/08/19
药物ATC编码
    • QP52AA51 praziquantel, combinations
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase